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1. Introduction
This chapter will be focused on epigenetic mechanisms known to affect self-renewal and
developmental potency of embryonic-like stem cells, and germ cells which mimic similar
epigenetic signatures as pluripotent stem cells. Examples of epigenetic regulation have proven
crucial for defining the stem cell state. In particular, a wealth of knowledge regarding stem
cell-specific epigenetic modifications has occurred over the past decade with discoveries that
include describing unique stem cell-specific chromosome structure, DNA and histone
modifications and noncoding RNAs. The impact of these findings and the better understand‐
ing of epigenetic regulation in pluripotent stem cells provides a foundation for discovering
mechanisms which regulate human development and differentiation in addition to those that
can facilitate cellular reprogramming.
In eukaryotes, chromosomes consist of repeating chromatin units called nucleosomes, which
encompass segments of DNA (~147 bp) wound around a central core of eight histone (H)
proteins (two each of core histone proteins H2A, H2B, H3, and H4). These units are separated
by a linker DNA associated with histone protein, H1. Post-translational modifications of these
histone residues regulate gene expression [1, 2]. The types of modification of specific amino
acids within these proteins include acetylation (Ac), mono- di- or tri-methylation (Me1, 2, 3),
and ubiquitylation (Ub). Although these mechanism in general appear to work independently,
recent evidence has demonstrated that crosstalk does exist between some of these modifica‐
tions [1, 3]. Chromatin can be distinguished based on its anatomical structure as either
heterochromatin or euchromatin. Heterochromatin is characterized by tightly packed nucle‐
osomes that occur at centromeres, telomeres, and areas of repetitive DNA and is associated
with low gene transcription while euchromatin constitute less compacted areas of chromatin
and associated with active gene expression. In general, these areas of chromatin are non-
randomly distributed within the nucleus and cell-type and cell-cycle dependent [4, 5].
© 2013 Eckert et al.; licensee InTech. This is an open access article distributed under the terms of the Creative
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In mammals, heterochromatin is associated with high levels of some methylation marks,
including lysine (K)-9, K-27 and K-20 on histone (H) -3 (H3K9me3, H3K27me3, H3K20me3),
low levels of acetylation, and its associated proteins including heterochromatin protein 1
(HP1) [6]. In contrast, euchromatin is associated with high levels of acetylation and methylation
marks, such as K-4, K-36, and K79 on Histone 3 (H3K4, H3K36 and H3K7)(reviewed by [1]).
These modifications occur through the activity of the following enzymes, histone acetyl
transferases (HATs), histone deacetylases (HDACs), histone methyltransferases (HMT) and
histone demethylases (HDMT). Further chromatin regulation is also possible through
modifications of the histone tails which are suspected to produce a ‘histone code’ that initiate
higher order chromatin folding [7].
2. Epigenetic control in pluripotent stem cells
2.1. Changes in chromatin ultrastructure in pluripotent stem cells
With the discovery of culturing embryonic stem cells (ESCs), several groups have been able to
show the progression of global changes in the chromatin architecture of these cells. Through
these studies, it has been shown that undifferentiated pluripotent stem cells contain less
heterochromatic regions and express less chromatin structural proteins. Moreover, binding of
these proteins (i.e. HP1α, lamin B) to heterochromatic regions is weaker compared to lineage-
committed cells [8]. Additionally, pluripotent transcription factors and chromatin remodeling
proteins are overexpressed in ESCs compared to more differentiated progenitor cells [9]. One
study further showed that chromatin remodeler Chd1 knockdown results with heterochro‐
matin accumulation and skewed differentiation in mouse ESCs, which suggests functional
relevancy to the ‘open’ chromatin structure [10]. Together, these studies show that pluripotent
ESCs has an open and hyperdynamic chromatin structure which transforms into a more
compact, repressive-like, chromatin state during differentiation.
As ESC chromatin is more transcriptionally permissive, it is also more sensitive to nuclease
activity. This may also be in part due to differences that are seen in the chromatin localization
in the nucleus. For instance, one study using the DamID (DNA adenine methyltransferase
identification) technique showed that pluripotency genes, including Oct4 and Nanog, move
to the nuclear lamina and are silenced while lineage-specific genes disassociate from the lamina
and are expressed. This was specifically shown during the differentiation of mouse ESCs into
terminal astrocytes which demonstrated cell type-specific relocations of these areas during
differentiation [11]. These areas near the nuclear periphery were called Lamina Associated
Domains (LADS). Further study showed that these areas were enriched with repressive
histone modifications, H3K9me2 and H3K27me3 which had tissue-specific distributions.
Additionally, they consisted of few, minimally expressed genes, which were also marked by
these repressive histone modifications [11-13].
Genome-wide ChIP analyses have also described other lamina associated domains with
significant overlap with the LADS domains. These regions referred as Large Organized
Chromatin domains of H3K9me2 or LOCKS, which are also hallmarked with increased
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H3K9me2 marks, gene-poor and increased in size and abundance from ESCs to differentiated
cells (from 4% genome coverage in mouse ESCs to at most 46%, in liver cells) [14]. Wen, Wu
et al. described these LOCKs as large regions with K9 modifications up to 4.9 Mb that are
conserved between human and mouse. Like LADS, LOCKS also show tissue-specific distri‐
butions and inversely correlate with gene expression. Specific knockouts of the H3K9 meth‐
yltransferase, G9a, abolished LOCK formation in mouse ESCs and caused gene derepression
without any peripheral localization alteration [14, 15]. Although LADS and LOCKS are similar
in their effects on gene expression and localization, the relationship between them and their
function at the nuclear periphery is presently unclear.
2.2. Bivalency
Since the discovery of generating induced pluripotent stem (iPS) cells, the ability to reprogram
a differentiated cell back towards a more embryonic-like state, it has been shown by a variety
of laboratories that there is an extensive amount of epigenetic variability between different iPS
lines and even among different clones. As a result, much research has been involved in
understanding the global demethylation and methylation patterns in ESC to identify particular
epigenetic marks and their effected genes to study their role in pluripotency and reprogram‐
ming. Methylation of DNA cytosine residues (mCG), particularly in CpG islands of promoters,
is a well-established mechanism that represses gene transcription in adult cells [16]. Several
studies have specifically shown in ESCs, that loss of DNA methyltransferases also compro‐
mises their ability to differentiate into mature cells without affecting their self-renewal [17].
In embryonic stem cells, lineage-specific gene expression program regulators are repressed,
but poised for a rapid response to differentiate [18]. These areas of chromatin, have so called
bivalent domains, consist of opposing chromatin marks; i.e. H3K4me for activation and
H3K27me for silencing. In ESCs, these domains are believed to be responsible for preventing
the transcription responsible for their early differentiation to a specific lineage while priming
the area for activation when the appropriate cues are expressed. Consistent with this belief is
the findings that the bulk of the protein-encoding genes of human ESCs, including transcrip‐
tionally inactive genes have H3K4me, H3K9ac and H3K14ac rich promoter regions in areas of
the nucleosome adjacent and downstream of transcription start sites [19, 20]. Moreover, in
ESCs, genes with bivalent gene promoters tend to have unmethylated CpG islands [21]. The
initial step of active DNA demethylation in mammals occurs by the conversion of 5-methyl‐
cytosine of DNA (5mC) to 5-hydroxymethylcytosine (5hmC). A prime example of this in
pluripotent stem cells has been shown in regulating the expression of the stem cell transcription
factor, Nanog. Here, the demethylated state is critical for the upregulation of Nanog which is
an essential regulator of ESC pluripotency and self-renewal, while its downregulation
attributed to methylation of its promoter is required for ICM specification [22]. Recent studies
demonstrate that demethylation of Nanog is in part contributed to the expression of the Tet
methylcytosine dioxygenase 1 (TET1) enzyme which is a TET family member of enzymes that
catalyze the conversion of 5mC to 5hmC. This enzyme has been found to demethylate Nanog
promoter sites in mouse ES cells [23, 24]. Both TET1 and TET2 expression have also been shown
to be regulated by Oct4 expression in mouse ES cells, downregulated following differentiation
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alongside other stem cell markers, and is induced concomitantly with 5-hmC during fibroblast
reprogramming into iPS cells [25].
In addition to promoter regulation, methylC-Seq genome-wide analysis has also discovered
novel types of DNA methylation regulation at non-CG sites (CHG and CHH sites where H =
A, C, or T residues). These analyses showed that non-CG methylation accounted for 25% of
the total ESC methylome and that these sites were more commonly found within gene bodies
than within promoter sites [26]. Furthermore, the methylation of these sites was lost when
differentiation was induced in ESCs, and restored during the generation of in induced
pluripotent stem cells. This included many differentially methylated regions associated with
genes involved in pluripotency and differentiation.
2.3. Polycomb and trithorax group proteins in pluripotent stem cells
Recent studies have established that developmental gene priming and bivalency are crucial
for pluripotency whereby the chromatin of pluripotent stem cells are transcriptionally
permissive, with normally silent DNA repeat regions, transcriptionally related histone
modifications such as H3K9ac, H3K4me3, H3K36me3 and low stochastic transcription of
lineage-restricted genes [8, 9]. The poised state is believed to inhibit the activity of RNA
Polymerase II (RNAP II) and thereby deregulate elongation. In the poised state, RNAP II
demonstrates high Ser5 phosphorylation and low levels of Ser2 phosphorylation which is in
part controlled by a number of complexes involved in this process. For this, several groups or
families of complexes involved in epigenetic regulation have been studied in pluripotent stem
cells. These proteins include those which regulate histone modifications, DNA methylation
and ATP-dependent chromatin remodelling and include the polycomb group (PcG) proteins,
trithorax group (TrxG) proteins, and ATP-dependent enzymes of the BAF complex. In general,
PcG proteins are usually associated with epigenetic gene silencing, while their antagonists
TrxG and BAF complexes proteins are involved in epigenetic maintenance or activation of
differentiation. The importance of these proteins in developmental regulation of gene expres‐
sion is well-established [27], while, their functions in adult and pluripotent stem cells is only
recently been understood [28]. This includes studies which show that PcG, TrxG, and other
chromatin remodeling factors including ATP-dependent enzymes are interconnected in their
roles to regulate pluripotency (see Figure 1) [29-33].
PcG, TrxG, and BAF complex associated genes are conserved from fly to man and are important
in the regulation of organogenesis and development. PcG proteins were initially discovered
as repressors of the Hox or homoeotic genes in Drosophila, while TrxG and BAP (BAF Droso‐
philia homolog) proteins maintained Hox gene expression in the appropriate spatial domains.
Hox genes encode a family of evolutionarily conserved regulators, which are involved in
establishing body segmentation patterns during the development of the fly. In mammalians,
these proteins also regulate genes involved in development and differentiation.
PcG proteins produce two distinct protein complexes that act sequentially to regulate gene
expression – the “Bmi-1 complex” also known as Polycomb Repressive Complexes (PRC1) and
the “Eed complex” also known as PRC2. The PRC1 or Bmi-1 complex includes Bmi-1, Ring1A/
B, Mph1/Rae28, Mel-18, M33, and Scmh1. The PRC2 or Eed complex includes Ezh1, Ezh2,
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PHF1, MTF2, Eed, YY1, RBBP4, RBBP7, PCL1, PCL2, PCL3, JARID2, AEBP2, and PHF19 and
Suz12 [34, 35]. Initial steps in stem cell reprogramming involves the recruitment of histone
deacetylase by activity of the PRC2 complex, which causes local deacetylation of chromatin
and subsequent methylation of K27 of histone H3. This H3K27 methylation then recruits the
Bmi-1 complex to the site, which leads to the monoubiquitination of Lys119 histone H2A, and
in turn suppresses gene expression [36]. The coordinative action of these two complexes plays
an important role in the regulation and maintenance of gene expression during development
and contributes to the epigenetic memory of stem cells [37, 38].
BAF complex > Nature Neuroscience 13, 1330–1337 (2010) doi:10.1038/nn.2671 Published online 26 October 2010
TrxG & PRCs : Cell Stem Cell. 2012 Jul 6;11(1):16-21. doi: 10.1016/j.stem.2012.06.005.
Figure 1. Chromatin remodeling factors of the TrxG, PRC1/2 and BAF complexes work together to regulate stem cell
status. In pluripotent stem cells, genes necessary for lineage-specific regulation consist of ‘bivalent’ chromatin do‐
mains that contain repressed H3K27me3 marks, as well as active H3K4me3 marks. These genes are then ‘primed’ for
rapid induction of expression upon receiving differentiation cues. Proteins of the TrxG family tri-methylate H3K4 lead‐
ing to active chromatin marks. PRC2 activity leads to repressive tri-methylation of H3K27 and subsequent recruitment
of PRC1 to the nucleosome region. Upon recruitment, PRC1 transfers a mono-ubiquitin residue to histone 2A
(H2AK119). Together, the binding of PRC1 and the ubiquitylation of H2AK119ub silences gene expression. BAF com‐
plexes directly unwind nucleosomal DNA by using ATP and helicase-like subunits. Together, these complexes coexist
and/or work hierarchically to regulate pluripotency and bivalency in stem cells.
Polycomb repressive complexes have been shown associated with many developmental
regulator regions in ESCs, and many of the PcG repressed targets of ESCs are also ‘bivalent’
[30, 39]. For instance, PRC2 target genes have been shown to be preferentially turned on during
ESC differentiation and that the pluripotent stem cell regulating genes Oct4, Sox2, and Nanog
co-occupy a significant subset of these genes. Therefore, it has been suggested that the PRC2
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complex represses a distinct group of developmental genes that have to be repressed to
maintain pluripotency. This would promote a poised or primed state which could be readily
activated during early differentiation [40]. For example, the histone methyltransferase Ezh2 is
known to catalyze H3K27me3. In fact, bivalency domains at PRC2 regulated promoters are
roughly five times more likely to become DNA methylated during differentiation than those
with non-PRC2 regulated promoters [21] suggesting that the PRC2 complex plays a pivotal
role in the switch for early lineage commitment [41]. Jarid2, a member of the Jumonji family
of histone demethylases, has also been shown to play an important role in properly recruiting
PRC1 and PRC2 and initiating the RNA Polymerase II activating form (Ser5P-RNAPII) [42] to
bivalent loci to promote differentiation [43-45]. While Jarid2 is enzymatically inactive in ESCs,
recent evidence has shown that Jarid2 is regulated by pluripotency factors in ESCs [43]. In null
ESCs lacking Jarid2 expression were able to self-renew but unable to differentiate despite
expressing appropriate PRC2 target genes demonstrating that transcriptional priming of
bivalent genes in ESCs was dependent on Jarid2 expression.
In addition to the bivalent marks associated with PRC2 associated H3 modifications in
pluripotent stem cells, bivalent genes in stem cells also exhibit repressive marks of
H2AK119Ub1 at their promoter and throughout the coding region. For this reason, members
of the PRC1 complex Ring1A and Ring1B proteins which catalyze H2AK119ub1 have also
reveal a role in regulating pluripotency [30, 46]. For instance, in ESCs, double mutants of
Ring1A/B demonstrate reduced levels of H2AK119Ub1, repression of known stemness genes
(including Oct4 targets), increased expression of developmental regulator targets, and
spontaneous differentiation. Furthermore, upon differentiation, Ring1A/B lost binding to their
target loci suggesting that a Ring 1/B mediated complex functions downstream of the stem cell
core transcriptional machinery to maintain the ESC state [47].
In addition to PcG complexes, core members of the TrxG and BAF chromatin remodeling
complexes have also been shown to contribute to the bivalent mark in stem cells by acting in
concert to establish and preserve H3K4me3 [48, 49]. Another core member, WD repeat domain
5 (Wdr5) of the TrxG complex, has also been associated with the undifferentiated state and
shown to regulate self-renewal in mouse ESCs [50]. This study went further to show that Wdr5
expression can promote efficient derivation of pluripotent iPS cells. Along with PcG and TrxG
complexes, other chromatin remodeling complexes have been shown to have crucial roles in
maintaining pluripotency. For instance, it has been shown that ESCs contain a unique BAF
complex, which distinguishes them from differentiated cell types. This ESC complex consists
of BAF60a, BAF155 and BRG subunits in the absence of BAF60c, BAF170 or BRM [48, 51].
Components of this ESC BAF complex also appear in RNAi screens for pluripotent genes [52,
53]. In mouse ESCs, it was also shown that BRG removal causes decreased self-renewal and
aberrant differentiation, whereas BRG withdrawal from differentiated cells had very little
effect [51]. Additionally, the pluripotency regulator genes Oct4, Sox2 and Nanog, have been
shown to be targeted by components of the ESC-specific BAF complex [48, 51, 54-56] as well
as facilitate IPS cell reprogramming [33].
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3. Epigenetic control in primordial germ cells and pluripotent embryonic
germ cells
Primordial germ cells (PGCs) are the progenitors of sperm and egg. In humans, these cells first
appear around the fifth week after conception and in mouse, during embryonic day (E) 5. At
this time, PGCs emerge from differentiated epiblast cells which have already begun to undergo
major epigenetic changes including DNA methylation and X inactivation [57]. Thus, epigenetic
regulation or reprogramming must occur in PGCs in order to achieve an undifferentiated
totipotent-like state [57, 58]. X activation and demethylation in PGCs is similar to that seen in
the process of generating ESCs and reprogramming somatic cells into pluripotent iPS cells [59].
Together, these epigenetic changes in germ cell development is to prevent the transmission of
aberrant epigenetic modifications to the next generation and to promote epigenetic equiva‐
lency in the germ line of male and female embryos, which is necessary for proper imprinting.
This is the only time in which homologous chromosomes are epigenetically indistinguishable
and in PGCs occurs primarily in the developing embryonic gonad [60, 61].
Key initiators of PGC induction in the epiblast include the Blimp1 (B-lymphocyte-induced
maturation protein 1), also known as PR domain zinc finger protein 1 (Prdm1), Prdm14 and
protein arginine methyltransferase 5 (Prmt5). These factors have been shown to initiate
epigenetic reprogramming and induce repression of the somatic program during germ cell
specification [62-64], and in a similar fashion to facilitate somatic cell reprogramming in iPS
cells and in epiblast stem cell generation [65, 66]. Their effects occur through both direct and
indirect targets. For instance, it is known that BLIMP1 associates with the arginine methyl‐
transferase PRMT5 to reduce expression of Hox-family genes and other somatic genes in PGCs
via H2A/H4 R3 methylation [67].
In addition to pluripotent associated genes, early germ-cell development and imprinted genes
also undergo demethylation during this time. These include well-established postmigratory
germ cell genes Mvh (also known as Ddx4), Sycp3 (synaptonemal complex protein 3) and Dazl
(deleted in azoospermia-like). These genes are demethylated in germ cells and repressed in
somatic cells. This demethylation occurs during the migration of PGCs into the gonad at CpG
islands of their promoters as well as at differentially methylated regions (DMRs) of imprinted
genes [68, 69]. Whether DNA methylation in PGCs is erased by an active or a passive mecha‐
nism is currently unclear. However, two DNA deaminases, activation-induced cytidine
deaminase (AID) and apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1
(APOBEC1) may demonstrate a key role in this process. While both enzymes have been shown
in vitro to deaminate 5-methylcytosine in DNA in mouse PGCs, deficiencies in AID expression
has also shown that it is essential for erasure of DNA methylation [70]. Both, Aid and Apobec1
are located in a cluster of genes which comprise Stella, Growth differentiation factor 3 (GDF3)
and Nanog. Stella, Gdf3 and Nanog are all expressed in pluripotent tissues as well as in germ
cells. [71]. While Stella is a known constituent of germ cell development, Gdf3 and Nanog have
important roles in conferring stem-cell identity on ES cells. It has also been suggested that in
vivo targeting in the zygote of AID to the methylated DMR of the imprinted gene H19 results
in efficient and substantial demethylation of this region [72]. Together these findings suggest
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an important role of AID in facilitating demethylation and reprogramming the pluripotent
state. Similar to AID, TET1 and TET2 may also play a facilitative role in PGC demethylation
as both TET enzymes are expressed in mouse PGCs during imprint erasure, concurrent with
5hmC enrichment [73].
Another important epigenetic process required for germ cell development and cellular
reprogramming to the pluripotent state involves the X chromosome. In female adult cells, one
of the two X chromosomes is inactivated to compensate for the differences in gene expression
between sexes. For this purpose, X chromosome inactivation is initiated in early embryos by
noncoding X-inactive specific transcript (Xist) RNA followed by chromatin modifications on
the inactive X chromosome which leads to stable gene repression in somatic cells. Likewise,
reactivation of the X chromosome is required for the totipotency of the female blastocyst and
germ cell development. Reactivation of the X chromosome also occurs to establish pluripo‐
tency in iPS cells. During development, epigenetic reprogramming or re-activation of the
inactive X-chromosome commences in PGCs during their migration through the hindgut along
their route to the developing gonads where imprint erasure is completed [74]. In mouse PGCs,
decreased Xist expression, and the displacement of PcG repressor proteins EED and SUZ12,
results in the loss of the inactive X associated histone modification, H3K27me3 [74]. In humans,
PcG proteins YY1, EZH2, and EED have also been found in the ovarian follicles, oocytes and
preimplantation embryos. YY1 and EZH2 transcripts were additionally detected in human
metaphase II oocytes suggesting they may be play a similar role in human germ cell reprog‐
ramming [75].
In vitro, PGCs cultured under specific conditions can also demonstrate epigenetic reprogram‐
ming with pluripotent cell-like characteristics. In these cases, PGCs form pluripotent stem cell
colonies called embryonic germ cells (EGCs) which have notable similarities in their epige‐
nomes [58, 76-82], and like ESCs, EGCs have been shown to induce epigenetic reprogramming
of somatic nucleus in hybrid cells [60].
4. MicroRNAs and stem cells
MicroRNAs (miRNAs) are a family of non-protein coding RNAs with transcripts of ~20–25
nucleotides that play essential roles in regulating gene expression (see [83-85]. A subset of
miRNAs have been shown to be preferentially expressed in undifferentiated stem cells and
for some, have been shown to play essential roles in pluripotency, proliferation, and modula‐
tion of expression patterns that are related to differentiation [86-89]. The promoter regions of
these miRNAs are often occupied by the pluripotency transcription factors, including Oct4,
Sox2, and Nanog [90]. In addition, during ESC differentiation, proteins modulated by miRNAs
[91] have also been shown to be modulated by PcG proteins [92]. For instance, Marson et al.
showed that approximately one quarter of the Oct4/Sox2/Nanog/Tcf3-occupied miRNAs
belonged to a set of repressed miRNA genes bound by Suz12 in murine ES cells [90]. Here, the
PRC2 complex protein SUZ12 was bound to a subset of inactive miRNAs controlling differ‐
entiation in mouse ESCs [90]. In this study, SUZ12 bound to the promoters of several miRNAs
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associated with repressing differentiation in ESCs. In a similar fashion, another PRC2 associ‐
ated factor, the transcription factor YY1 has also been shown to directly regulate miR-29
transcription through the recruitment of HDAC1 and EZH2 to the regulatory regions of the
miR-29 promoter [93].
Studies in mice have shown that induction of neural differentiation in mouse ESCs with
retinoic acid results in increased miR-134, miR-296, and miR-470 which in turn interact with
the coding sequences of the pluripotency transcription factors Oct4, Sox2, and Nanog. These
results suggest that through interaction of the miRNAs these pluripotent stem cells genes are
downregulated thereby permitting differentiation to proceed [91]. Additionally, the ESC-
specific miR-290 cluster has also been shown to regulate Oct4 methylation in differentiating
ESCs [94]. Other studies have shown that mouse ESCs deficient in proteins of the miRNA
processing apparatus such as Dicer, Drosha, DGCR8, and Ddx5 exhibit differentiation and
developmental defects [95-97].
Interestingly, PcG proteins have been shown to be both regulators of miRNA expression as
well as their targets. For instance, miRNA-101 has been shown to directly regulate the
expression of the PRC protein EZH2 in highly aggressive cancers [98, 99].
5. Epigenetic regulation in progenitor and adult stem cells
Progenitor cells and adult stem cells are thought to be predecessors of pluripotent or multi‐
potent stem cells that are generated during early differentiation. During their transition in
development, bivalently marked stem cell genes can become either active, or inactive, or
remain bivalent, dependent in part, on the activity of key enzymes which drive these chromatin
modifications such as lysine demethylases (KDMs), histone deubiquitylases (DUBs), and
DNA methyltransferases (DNMTs). Bivalent chromatin, although present in progenitor cells,
is less frequent than in pluripotent stem cells. This has been shown in mesenchymal stem cells,
hematopoietic stem cells and neural progenitors, in which cases the bivalency continues to
resolve upon further differentiation [100]. During this process in pluripotent stem cells, active
genes exhibit diminishing suppressive chromatin marks, an increase in H3K4me3, gain of
H3K36me3 within coding sequences of DNA, and contain RNAP II that carries high Ser5
phosphorylation and low levels of Ser2 phosphorylation near promoter and within coding
regions. Moreover, inactive genes show loss of active chromatin marks while retaining
repressive ones, and in some cases gaining CpG methylation (mCpG).
Specific differences occur in the chromatin states between pluripotent stem cells, progenitor
cells and more differentiated cell types which include active, repressed and poised states of
chromatin. Several lines of evidence suggest that priming in the poised state enables genes to
respond rapidly when differentiation cues are presented [30]. For example, during neural
induction, several hundred genes including those required to maintain stem cell-ness become
de novo mCG and therefore transcriptionally silenced. Furthermore, the observation was
made that neural precursors that are derived from ESCs acquired more mCG than terminal
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neurons, suggesting that the transition from pluripotent to lineage-committed cells is associ‐
ated with these changes [17, 21, 101, 102].
Polycomb group proteins also appear to play a unique role in defining the progenitor or adult
stem cell state. It has been shown that the PRC1 complex protein Bmi-1 activates multiple
pathways that are important for regulating the stem cell-like state. For example, it has been
shown that Bmi-1 is potentially upregulated via the pluripotent stem cell marker SALL4
signaling and has been shown to regulate stem cell self-renewal by repressing Hox genes, as
well as INK4a locus genes, p16INK4a and p19ARF. BMI1 has also been shown to facilitate stem
cell-like features in adult stem cells such as increased telomerase activity, transcriptional factor
GATA3, and NF-kB pathways. These pathways are associated with the prevention of senes‐
cence, differentiation and apoptosis, while promoting immortalization and proliferation (for
review see [103]).
6. Epigenetic dysregulation in cancer stem cells
Cancer stem/initiating cells (CSC) have been defined as a subset of cancer cells that have clonal
ability or self-renewal and are resilient against cancer therapies [104, 105]. As such CSCs are
implicated in cancer initiation, metastasis, and recurrence of some cancers [106]. Although the
most well established pluripotent stem cell genes OCT4, NANOG, cMYC and SOX2 are
implicated in many poorly differentiated or metastatic cancers [107-109], they are not ex‐
pressed in all and they are not all elevated concordantly. In addition, targets of NANOG, OCT4,
SOX2, and c-MYC are often overexpressed in tumors that are poorly differentiated, more so
than in those that are well differentiated [110]. These genes also play a significant role in the
induction of pluripotency into iPS cells from differentiated cell types and are thus involved in
regulating epigenetic reprogramming [111-113]. More specifically, it is found that c-MYC,
which is also an oncogene is sufficient for the reactivation of ESC-like transcriptional program
in both, normal and cancer cells [114]. Additionally, studies have shown that one of the
inherent issues with generating iPS cells is their propensity to become cancer stem cell-like
[115, 116]. Taken together, these results indicate that aberrant activation of an ESC or iPS-like
transcriptional program might cause induction of pathological self-renewal in adult differen‐
tiated cells, characteristic of cancer stem cells.
Aberrant function of PcG proteins has also been established in the malignancy of various
cancers [117]. This is not surprising as it is well known that polycomb complexes contribute
to the epigenetic regulation of key networks associated with self-renewal [118], differentiation,
and proliferation [92, 119-123]. These roles for polycombs have been demonstrated in cancer
cells and normal stem cells [124] and more recently studied for their targeted function in CSCs
[125]. For instance, there is much evidence that overexpression of the EZH2 polycomb gene
occurs in multiple human malignancies (see [117, 126]). One study showed that this may in
part be atributed to a genomic loss of miR-101 which has been shown to lead to increased EZH2
levels [99, 127]. Although how EZH2 contributes to carcinogenesis remains poorly defined,
recent evidence suggests that overexpression of EZH2 can contribute to improper silencing of
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tumor suppressor genes [121]. In this case, EZH2 was shown to target a pro-differentiation
tumor suppressor gene, retinoic acid receptor β2 (RARβ2) [120], which is reduced or lost in
many human malignancies.
7. Conclusion
The pluripotent stem cells have a chromatin that is hyperdynamic, with a preponderance of
modified histones and chromatin remodelers that ensures low-level transcription and tight
regulation. Losing pluripotency is accompanied with a more compact, repressive, chromatin
structure, which leads to cellular differentiation. Chromatin architecture is regulated at
multiple levels in conjunction with known pluripotent genes to constitute an interwoven
pluripotency network. Although there are many gaps in our knowledge of how epigenetic
modifications regulate the pluripotent state, it is known that PcG repressor proteins prevent
the precocious expression of lineage-restricted gene expression in pluripotent stem cells and
germ cells by contributing to a unique ‘primed’ bivalent state of the chromatin. Future studies
will provide mechanistic insights into the signaling cues required to maintain this state and
inhibit differentiation while iPS cells and adult stem cells provide a renewed opportunity to
study the role of chromatin architecture for controlling the pluripotent state. This will include
understanding the mechanisms that interplay between pluripotent transcription factors,
epigenetic regulators, and miRNAs to balance self-renewal and differentiation, properties
which regulate reprogramming and carcinogenesis.
Nomenclature
cdk, cyclin-dependent kinase; H2A-K119-Ub, ubiquitinylated histone H2A lysine 119;
H3K27me3, tri-methylated histone H3 lysine K27; PcG, Polycomb group genes; ESC, embry‐
onic stem cells; EGC, embryonic germ cells; PGC, primordial germ cells; iPS, induced pluri‐
potent stem cells; CSC, cancer stem cells; RARβ2, retinoic acid receptor β2; Hh, Hedghog;
KDMs, lysine demethylases; DUBs, histone deubiquitylases; DNMT, DNA methyltransferas‐
es; YY1, Ying Yang 1; EZH2 Enhancer of Zeste-2; EED, embryonic ectoderm development;
GDF3, growth differentiation factor 3; DMR, differentially methylated regions; DAZL. deleted
in azoospermia-like; Mvh, deadhead box 4; Sycp3, synaptonemal complex protein 3; E,
embryonic day; RNAP II, RNA Polymerase II; trxG, trithorax group proteins; AID, activation-
induced cytidine deaminase; APOBEC1, apolipoprotein B mRNA editing enzyme, catalytic
polypeptide 1
Acknowledgements
This work was supported by NIH grants R01 AR053851 and R01 CA131074 to R Eckert and
R21HD057487 awarded to C Kerr as well as by the State of Maryland Stem Cell Research Fund
2010-MSCRFI-0110-00 to R Eckert and 2007-MSCRFII-0159-00 awarded to C Kerr.




Richard L. Eckert1,2,3,4, Yasin Kizilyer1 and Candace L. Kerr1*
*Address all correspondence to: ckerr@som.umaryland.edu
1 Department of Biochemistry and Molecular Biology, University of Maryland School of
Medicine, Baltimore, Maryland, USA
2  Department  of  Reproductive  Sciences,  University  of  Maryland  School  of  Medicine,
Baltimore,  Maryland,  USA
3 Department of Dermatology, University of Maryland School of Medicine, Baltimore,
Maryland, USA
4  Department  of  Microbiology  and  Immunology,  University  of  Maryland  School  of
Medicine,  Baltimore,  Maryland,  USA
References
[1] Kouzarides T. Chromatin modifications and their function. Cell. 2007 Feb 23;128(4):
693-705.
[2] Vermeulen M, Eberl HC, Matarese F, Marks H, Denissov S, Butter F, et al. Quantita‐
tive interaction proteomics and genome-wide profiling of epigenetic histone marks
and their readers. Cell. 2010 Sep 17;142(6):967-80.
[3] Lee JS, Smith E, Shilatifard A. The language of histone crosstalk. Cell. 2010 Sep
3;142(5):682-5.
[4] Joffe B, Leonhardt H, Solovei I. Differentiation and large scale spatial organization of
the genome. Curr Opin Genet Dev. 2010 Oct;20(5):562-9.
[5] Fisher CL, Fisher AG. Chromatin states in pluripotent, differentiated, and reprog‐
rammed cells. Curr Opin Genet Dev. 2011 Apr;21(2):140-6.
[6] Kloc A, Martienssen R. RNAi, heterochromatin and the cell cycle. Trends Genet. 2008
Oct;24(10):511-7.
[7] Strahl BD, Allis CD. The language of covalent histone modifications. Nature. 2000
Jan 6;403(6765):41-5.
[8] Mattout A, Meshorer E. Chromatin plasticity and genome organization in pluripo‐
tent embryonic stem cells. Curr Opin Cell Biol. 2010 Jun;22(3):334-41.
Pluripotent Stem Cells216
[9] Efroni S, Duttagupta R, Cheng J, Dehghani H, Hoeppner DJ, Dash C, et al. Global
transcription in pluripotent embryonic stem cells. Cell Stem Cell. 2008 May 8;2(5):
437-47.
[10] Gaspar-Maia A, Alajem A, Polesso F, Sridharan R, Mason MJ, Heidersbach A, et al.
Chd1 regulates open chromatin and pluripotency of embryonic stem cells. Nature.
2009 Aug 13;460(7257):863-8.
[11] Peric-Hupkes D, Meuleman W, Pagie L, Bruggeman SW, Solovei I, Brugman W, et al.
Molecular maps of the reorganization of genome-nuclear lamina interactions during
differentiation. Mol Cell. 2010 May 28;38(4):603-13.
[12] Guelen L, Pagie L, Brasset E, Meuleman W, Faza MB, Talhout W, et al. Domain or‐
ganization of human chromosomes revealed by mapping of nuclear lamina interac‐
tions. Nature. 2008 Jun 12;453(7197):948-51.
[13] Pickersgill H, Kalverda B, de Wit E, Talhout W, Fornerod M, van Steensel B. Charac‐
terization of the Drosophila melanogaster genome at the nuclear lamina. Nat Genet.
2006 Sep;38(9):1005-14.
[14] Wen B, Wu H, Shinkai Y, Irizarry RA, Feinberg AP. Large histone H3 lysine 9 dime‐
thylated chromatin blocks distinguish differentiated from embryonic stem cells. Nat
Genet. 2009 Feb;41(2):246-50.
[15] Yokochi T, Poduch K, Ryba T, Lu J, Hiratani I, Tachibana M, et al. G9a selectively re‐
presses a class of late-replicating genes at the nuclear periphery. Proc Natl Acad Sci
U S A. 2009 Nov 17;106(46):19363-8.
[16] Cedar H, Bergman Y. Linking DNA methylation and histone modification: patterns
and paradigms. Nat Rev Genet. 2009 May;10(5):295-304.
[17] Trowbridge JJ, Orkin SH. DNA methylation in adult stem cells: New insights into
self-renewal. Epigenetics. 2010 Apr 31;5(3).
[18] Bernstein BE, Mikkelsen TS, Xie X, Kamal M, Huebert DJ, Cuff J, et al. A bivalent
chromatin structure marks key developmental genes in embryonic stem cells. Cell.
2006 Apr 21;125(2):315-26.
[19] Guenther MG, Levine SS, Boyer LA, Jaenisch R, Young RA. A chromatin landmark
and transcription initiation at most promoters in human cells. Cell. 2007 Jul 13;130(1):
77-88.
[20] Roelen BA, Lopes SM. Of stem cells and gametes: similarities and differences. Curr
Med Chem. 2008;15(13):1249-56.
[21] Mohn F, Weber M, Rebhan M, Roloff TC, Richter J, Stadler MB, et al. Lineage-specific
polycomb targets and de novo DNA methylation define restriction and potential of
neuronal progenitors. Mol Cell. 2008 Jun 20;30(6):755-66.
Epigenetic Reprogramming in Stem Cells
http://dx.doi.org/10.5772/56327
217
[22] Ito S, D'Alessio AC, Taranova OV, Hong K, Sowers LC, Zhang Y. Role of Tet proteins
in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification.
Nature. 2010 Aug 26;466(7310):1129-33.
[23] Ito S, Shen L, Dai Q, Wu SC, Collins LB, Swenberg JA, et al. Tet proteins can convert
5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science. 2010 Sep
2;333(6047):1300-3.
[24] Tahiliani M, Koh KP, Shen Y, Pastor WA, Bandukwala H, Brudno Y, et al. Conver‐
sion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL
partner TET1. Science. 2009 May 15;324(5929):930-5.
[25] Koh KP, Yabuuchi A, Rao S, Huang Y, Cunniff K, Nardone J, et al. Tet1 and Tet2 reg‐
ulate 5-hydroxymethylcytosine production and cell lineage specification in mouse
embryonic stem cells. Cell Stem Cell. 2011 Feb 4;8(2):200-13.
[26] Lister R, Pelizzola M, Dowen RH, Hawkins RD, Hon G, Tonti-Filippini J, et al. Hu‐
man DNA methylomes at base resolution show widespread epigenomic differences.
Nature. 2009 Nov 19;462(7271):315-22.
[27] Simon JA, Kingston RE. Mechanisms of polycomb gene silencing: knowns and un‐
knowns. Nat Rev Mol Cell Biol. 2009 Oct;10(10):697-708.
[28] Sauvageau M, Sauvageau G. Polycomb group genes: keeping stem cell activity in
balance. PLoS Biol. 2008 Apr 29;6(4):e113.
[29] Cole MF, Young RA. Mapping key features of transcriptional regulatory circuitry in
embryonic stem cells. Cold Spring Harb Symp Quant Biol. 2008;73:183-93.
[30] Surface LE, Thornton SR, Boyer LA. Polycomb group proteins set the stage for early
lineage commitment. Cell Stem Cell. 2010 Sep 3;7(3):288-98.
[31] Ho L, Crabtree GR. Chromatin remodelling during development. Nature. 2010 Jan
28;463(7280):474-84.
[32] Pietersen AM, van Lohuizen M. Stem cell regulation by polycomb repressors: post‐
poning commitment. Curr Opin Cell Biol. 2008 Apr;20(2):201-7.
[33] Singhal N, Graumann J, Wu G, Arauzo-Bravo MJ, Han DW, Greber B, et al. Chroma‐
tin-Remodeling Components of the BAF Complex Facilitate Reprogramming. Cell.
2010 Jun 11;141(6):943-55.
[34] Sauvageau M, Sauvageau G. Polycomb group proteins: multi-faceted regulators of
somatic stem cells and cancer. Cell Stem Cell. 2010 Sep 3;7(3):299-313.
[35] Wu H, D'Alessio AC, Ito S, Wang Z, Cui K, Zhao K, et al. Genome-wide analysis of 5-
hydroxymethylcytosine distribution reveals its dual function in transcriptional regu‐
lation in mouse embryonic stem cells. Genes Dev. 2011 Apr 1;25(7):679-84.
Pluripotent Stem Cells218
[36] Fischle W, Wang Y, Jacobs SA, Kim Y, Allis CD, Khorasanizadeh S. Molecular basis
for the discrimination of repressive methyl-lysine marks in histone H3 by Polycomb
and HP1 chromodomains. Genes Dev. 2003 Aug 1;17(15):1870-81.
[37] Jacobs SA, Khorasanizadeh S. Structure of HP1 chromodomain bound to a lysine 9-
methylated histone H3 tail. Science. 2002 Mar 15;295(5562):2080-3.
[38] Orlando V. Polycomb, epigenomes, and control of cell identity. Cell. 2003 Mar
7;112(5):599-606.
[39] Spivakov M, Fisher AG. Epigenetic signatures of stem-cell identity. Nat Rev Genet.
2007 Apr;8(4):263-71.
[40] Lee TI, Jenner RG, Boyer LA, Guenther MG, Levine SS, Kumar RM, et al. Control of
developmental regulators by Polycomb in human embryonic stem cells. Cell. 2006
Apr 21;125(2):301-13.
[41] Landeira D, Fisher AG. Inactive yet indispensable: the tale of Jarid2. Trends Cell Biol.
2011 Feb;21(2):74-80.
[42] Brookes E, Pombo A. Modifications of RNA polymerase II are pivotal in regulating
gene expression states. EMBO Rep. 2009 Nov;10(11):1213-9.
[43] Landeira D, Sauer S, Poot R, Dvorkina M, Mazzarella L, Jorgensen HF, et al. Jarid2 is
a PRC2 component in embryonic stem cells required for multi-lineage differentiation
and recruitment of PRC1 and RNA Polymerase II to developmental regulators. Nat
Cell Biol. 2010 Jun;12(6):618-24.
[44] Pasini D, Cloos PA, Walfridsson J, Olsson L, Bukowski JP, Johansen JV, et al. JARID2
regulates binding of the Polycomb repressive complex 2 to target genes in ES cells.
Nature. 2010 Mar 11;464(7286):306-10.
[45] Shen X, Kim W, Fujiwara Y, Simon MD, Liu Y, Mysliwiec MR, et al. Jumonji modu‐
lates polycomb activity and self-renewal versus differentiation of stem cells. Cell.
2009 Dec 24;139(7):1303-14.
[46] Eskeland R, Leeb M, Grimes GR, Kress C, Boyle S, Sproul D, et al. Ring1B compacts
chromatin structure and represses gene expression independent of histone ubiquiti‐
nation. Mol Cell. 2010 May 14;38(3):452-64.
[47] Endoh M, Endo TA, Endoh T, Fujimura Y, Ohara O, Toyoda T, et al. Polycomb group
proteins Ring1A/B are functionally linked to the core transcriptional regulatory cir‐
cuitry to maintain ES cell identity. Development. 2008 Apr;135(8):1513-24.
[48] Ho L, Jothi R, Ronan JL, Cui K, Zhao K, Crabtree GR. An embryonic stem cell chro‐
matin remodeling complex, esBAF, is an essential component of the core pluripoten‐
cy transcriptional network. Proc Natl Acad Sci U S A. 2009 Mar 31;106(13):5187-91.
[49] Lessard JA, Crabtree GR. Chromatin regulatory mechanisms in pluripotency. Annu
Rev Cell Dev Biol. 2010 Nov 10;26:503-32.
Epigenetic Reprogramming in Stem Cells
http://dx.doi.org/10.5772/56327
219
[50] Ang YS, Tsai SY, Lee DF, Monk J, Su J, Ratnakumar K, et al. Wdr5 mediates self-re‐
newal and reprogramming via the embryonic stem cell core transcriptional network.
Cell. 2010 Apr 15;145(2):183-97.
[51] Ho L, Ronan JL, Wu J, Staahl BT, Chen L, Kuo A, et al. An embryonic stem cell chro‐
matin remodeling complex, esBAF, is essential for embryonic stem cell self-renewal
and pluripotency. Proc Natl Acad Sci U S A. 2009 Mar 31;106(13):5181-6.
[52] Fazzio TG, Huff JT, Panning B. An RNAi screen of chromatin proteins identifies
Tip60-p400 as a regulator of embryonic stem cell identity. Cell. 2008 Jul 11;134(1):
162-74.
[53] Schaniel C, Ang YS, Ratnakumar K, Cormier C, James T, Bernstein E, et al. Smarcc1/
Baf155 couples self-renewal gene repression with changes in chromatin structure in
mouse embryonic stem cells. Stem Cells. 2009 Dec;27(12):2979-91.
[54] Liang J, Wan M, Zhang Y, Gu P, Xin H, Jung SY, et al. Nanog and Oct4 associate with
unique transcriptional repression complexes in embryonic stem cells. Nat Cell Biol.
2008 Jun;10(6):731-9.
[55] Pardo M, Lang B, Yu L, Prosser H, Bradley A, Babu MM, et al. An expanded Oct4
interaction network: implications for stem cell biology, development, and disease.
Cell Stem Cell. 2010 Apr 2;6(4):382-95.
[56] van den Berg DL, Snoek T, Mullin NP, Yates A, Bezstarosti K, Demmers J, et al. An
Oct4-centered protein interaction network in embryonic stem cells. Cell Stem Cell.
2010 Apr 2;6(4):369-81.
[57] Hayashi K, Surani MA. Resetting the epigenome beyond pluripotency in the germ‐
line. Cell Stem Cell. 2009 Jun 5;4(6):493-8.
[58] Surani MA, Hayashi K, Hajkova P. Genetic and epigenetic regulators of pluripoten‐
cy. Cell. 2007 Feb 23;128(4):747-62.
[59] Monk M, Boubelik M, Lehnert S. Temporal and regional changes in DNA methyla‐
tion in the embryonic, extraembryonic and germ cell lineages during mouse embryo
development. Development. 1987 Mar;99(3):371-82.
[60] Tada M, Tada T, Lefebvre L, Barton SC, Surani MA. Embryonic germ cells induce ep‐
igenetic reprogramming of somatic nucleus in hybrid cells. Embo J. 1997 Nov
3;16(21):6510-20.
[61] Hajkova P, Ancelin K, Waldmann T, Lacoste N, Lange UC, Cesari F, et al. Chromatin
dynamics during epigenetic reprogramming in the mouse germ line. Nature. 2008
Apr 17;452(7189):877-81.
[62] Ohinata Y, Payer B, O'Carroll D, Ancelin K, Ono Y, Sano M, et al. Blimp1 is a critical
determinant of the germ cell lineage in mice. Nature. 2005 Jul 14;436(7048):207-13.
[63] Vincent SD, Dunn NR, Sciammas R, Shapiro-Shalef M, Davis MM, Calame K, et al.
The zinc finger transcriptional repressor Blimp1/Prdm1 is dispensable for early axis
Pluripotent Stem Cells220
formation but is required for specification of primordial germ cells in the mouse. De‐
velopment. 2005 Mar;132(6):1315-25.
[64] Yamaji M, Seki Y, Kurimoto K, Yabuta Y, Yuasa M, Shigeta M, et al. Critical function
of Prdm14 for the establishment of the germ cell lineage in mice. Nat Genet. 2008
Aug;40(8):1016-22.
[65] Gillich A, Bao S, Grabole N, Hayashi K, Trotter MW, Pasque V, et al. Epiblast stem
cell-based system reveals reprogramming synergy of germline factors. Cell Stem
Cell. 2012 Apr 6;10(4):425-39.
[66] Nagamatsu G, Kosaka T, Kawasumi M, Kinoshita T, Takubo K, Akiyama H, et al. A
germ cell-specific gene, Prmt5, works in somatic cell reprogramming. J Biol Chem.
2011 Mar 25;286(12):10641-8.
[67] Ancelin K, Lange UC, Hajkova P, Schneider R, Bannister AJ, Kouzarides T, et al.
Blimp1 associates with Prmt5 and directs histone arginine methylation in mouse
germ cells. Nat Cell Biol. 2006;8(6):623-30.
[68] Maatouk DM, Kellam LD, Mann MR, Lei H, Li E, Bartolomei MS, et al. DNA methyl‐
ation is a primary mechanism for silencing postmigratory primordial germ cell genes
in both germ cell and somatic cell lineages. Development. 2006 Sep;133(17):3411-8.
[69] Reik W, Dean W. Back to the beginning. Nature. 2002 Nov 14;420(6912):127.
[70] Popp C, Dean W, Feng S, Cokus SJ, Andrews S, Pellegrini M, et al. Genome-wide era‐
sure of DNA methylation in mouse primordial germ cells is affected by AID deficien‐
cy. Nature. 2010 Feb 25;463(7284):1101-5.
[71] Morgan HD, Dean W, Coker HA, Reik W, Petersen-Mahrt SK. Activation-induced
cytidine deaminase deaminates 5-methylcytosine in DNA and is expressed in pluri‐
potent tissues: implications for epigenetic reprogramming. J Biol Chem. 2004 Dec
10;279(50):52353-60.
[72] Reik W. Stability and flexibility of epigenetic gene regulation in mammalian develop‐
ment. Nature. 2007 May 24;447(7143):425-32.
[73] Hackett JA, Sengupta R, Zylicz JJ, Murakami K, Lee C, Down TA, et al. Germline
DNA Demethylation Dynamics and Imprint Erasure Through 5-Hydroxymethylcy‐
tosine. Science. 2012 Dec 13.
[74] de Napoles M, Nesterova T, Brockdorff N. Early loss of Xist RNA expression and in‐
active X chromosome associated chromatin modification in developing primordial
germ cells. PLoS One. 2007;2(9):e860.
[75] Hinkins M, Huntriss J, Miller D, Picton HM. Expression of Polycomb-group genes in
human ovarian follicles, oocytes and preimplantation embryos. Reproduction. 2005
Dec;130(6):883-8.
[76] Labosky PA, Barlow DP, Hogan BL. Mouse embryonic germ (EG) cell lines: transmis‐
sion through the germline and differences in the methylation imprint of insulin-like
Epigenetic Reprogramming in Stem Cells
http://dx.doi.org/10.5772/56327
221
growth factor 2 receptor (Igf2r) gene compared with embryonic stem (ES) cell lines.
Development. 1994 Nov;120(11):3197-204.
[77] Tada T, Tada M, Hilton K, Barton SC, Sado T, Takagi N, et al. Epigenotype switching
of imprintable loci in embryonic germ cells. Dev Genes Evol. 1998 Feb;207(8):551-61.
[78] Onyango P, Jiang S, Uejima H, Shamblott MJ, Gearhart JD, Cui H, et al. Monoallelic
expression and methylation of imprinted genes in human and mouse embryonic
germ cell lineages. Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10599-604.
[79] Matsui Y, Zsebo K, Hogan BL. Derivation of pluripotential embryonic stem cells
from murine primordial germ cells in culture. Cell. 1992;70(5):841-7.
[80] Stewart CL, Gadi I, Bhatt H. Stem cells from primordial germ cells can reenter the
germ line. Dev Biol. 1994 Feb;161(2):626-8.
[81] Shamblott MJ, Axelman J, Wang S, Bugg EM, Littlefield JW, Donovan PJ, et al. Deri‐
vation of pluripotent stem cells from cultured human primordial germ cells. Pro‐
ceedings of the National Academy of Sciences of the United States of America.
1998;95(23):13726-31.
[82] Hiller M, Liu C, Blumenthal PD, Gearhart JD, Kerr CL. Bone morphogenetic protein
4 mediates human embryonic germ cell derivation. Stem Cells Dev. 2011 Feb;20(2):
351-61.
[83] Kashyap V, Rezende NC, Scotland KB, Shaffer SM, Persson JL, Gudas LJ, et al. Regu‐
lation of stem cell pluripotency and differentiation involves a mutual regulatory cir‐
cuit of the NANOG, OCT4, and SOX2 pluripotency transcription factors with
polycomb repressive complexes and stem cell microRNAs. Stem Cells Dev. 2009 Sep;
18(7):1093-108.
[84] Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009 Jan
23;136(2):215-33.
[85] Gangaraju VK, Lin H. MicroRNAs: key regulators of stem cells. Nat Rev Mol Cell Bi‐
ol. 2009 Feb;10(2):116-25.
[86] Houbaviy HB, Murray MF, Sharp PA. Embryonic stem cell-specific MicroRNAs. Dev
Cell. 2003 Aug;5(2):351-8.
[87] Barroso-delJesus A, Romero-Lopez C, Lucena-Aguilar G, Melen GJ, Sanchez L, Li‐
gero G, et al. Embryonic stem cell-specific miR302-367 cluster: human gene structure
and functional characterization of its core promoter. Mol Cell Biol. 2008 Nov;28(21):
6609-19.
[88] Letzen B, Liu C, Thakor N, Gearhart J, All A, Kerr C. MicroRNA Expression Profiling
of Oligodendrocyte Differentiation from Human Embryonic Stem Cells. PLoS one.
2010;5(5):e10480 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2864763/.
Pluripotent Stem Cells222
[89] Lakshmipathy U, Love B, Goff LA, Jornsten R, Graichen R, Hart RP, et al. MicroRNA
Expression Pattern of Undifferentiated and Differentiated Human Embryonic Stem
Cells. Stem Cells Dev. 2007 Dec;16(6):1003-16.
[90] Marson A, Levine SS, Cole MF, Frampton GM, Brambrink T, Johnstone S, et al. Con‐
necting microRNA genes to the core transcriptional regulatory circuitry of embryonic
stem cells. Cell. 2008 Aug 8;134(3):521-33.
[91] Tay Y, Zhang J, Thomson AM, Lim B, Rigoutsos I. MicroRNAs to Nanog, Oct4 and
Sox2 coding regions modulate embryonic stem cell differentiation. Nature. 2008 Oct
23;455(7216):1124-8.
[92] Pasini D, Bracken AP, Helin K. Polycomb group proteins in cell cycle progression
and cancer. Cell Cycle. 2004 Apr;3(4):396-400.
[93] Wang H, Garzon R, Sun H, Ladner KJ, Singh R, Dahlman J, et al. NF-kappaB-YY1-
miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma. Cancer
Cell. 2008 Nov 4;14(5):369-81.
[94] Sinkkonen L, Hugenschmidt T, Berninger P, Gaidatzis D, Mohn F, Artus-Revel CG,
et al. MicroRNAs control de novo DNA methylation through regulation of transcrip‐
tional repressors in mouse embryonic stem cells. Nat Struct Mol Biol. 2008 Mar;15(3):
259-67.
[95] Kanellopoulou C, Muljo SA, Kung AL, Ganesan S, Drapkin R, Jenuwein T, et al. Dic‐
er-deficient mouse embryonic stem cells are defective in differentiation and centro‐
meric silencing. Genes Dev. 2005 Feb 15;19(4):489-501.
[96] Wang Y, Medvid R, Melton C, Jaenisch R, Blelloch R. DGCR8 is essential for micro‐
RNA biogenesis and silencing of embryonic stem cell self-renewal. Nat Genet. 2007
Mar;39(3):380-5.
[97] Fukuda T, Yamagata K, Fujiyama S, Matsumoto T, Koshida I, Yoshimura K, et al.
DEAD-box RNA helicase subunits of the Drosha complex are required for processing
of rRNA and a subset of microRNAs. Nat Cell Biol. 2007 May;9(5):604-11.
[98] Banerjee R, Mani RS, Russo N, Scanlon CS, Tsodikov A, Jing X, et al. The tumor sup‐
pressor gene rap1GAP is silenced by miR-101-mediated EZH2 overexpression in in‐
vasive squamous cell carcinoma. Oncogene. 2011 Oct 20;30(42):4339-49.
[99] Varambally S, Cao Q, Mani RS, Shankar S, Wang X, Ateeq B, et al. Genomic loss of
microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer.
Science. 2008 Dec 12;322(5908):1695-9.
[100] Cui K, Zang C, Roh TY, Schones DE, Childs RW, Peng W, et al. Chromatin signatures
in multipotent human hematopoietic stem cells indicate the fate of bivalent genes
during differentiation. Cell Stem Cell. 2009 Jan 9;4(1):80-93.
Epigenetic Reprogramming in Stem Cells
http://dx.doi.org/10.5772/56327
223
[101] Collas P. Programming differentiation potential in mesenchymal stem cells. Epige‐
netics. 2010 Aug 16;5(6):476-82.
[102] Meissner A, Mikkelsen TS, Gu H, Wernig M, Hanna J, Sivachenko A, et al. Genome-
scale DNA methylation maps of pluripotent and differentiated cells. Nature. 2008
Aug 7;454(7205):766-70.
[103] Jiang L, Li J, Song L. Bmi-1, stem cells and cancer. Acta Biochim Biophys Sin (Shang‐
hai). 2009 Jul;41(7):527-34.
[104] Clarke MF, Fuller M. Stem cells and cancer: two faces of eve. Cell. 2006 Mar 24;124(6):
1111-5.
[105] Hill RP, Perris R. "Destemming" cancer stem cells. J Natl Cancer Inst. 2007 Oct
3;99(19):1435-40.
[106] Dalerba P, Cho RW, Clarke MF. Cancer stem cells: models and concepts. Annu Rev
Med. 2007;58:267-84.
[107] Mongan NP, Martin KM, Gudas LJ. The putative human stem cell marker, Rex-1
(Zfp42): structural classification and expression in normal human epithelial and car‐
cinoma cell cultures. Mol Carcinog. 2006 Dec;45(12):887-900.
[108] Chiou SH, Yu CC, Huang CY, Lin SC, Liu CJ, Tsai TH, et al. Positive correlations of
Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell
carcinoma. Clin Cancer Res. 2008 Jul 1;14(13):4085-95.
[109] Raman JD, Mongan NP, Liu L, Tickoo SK, Nanus DM, Scherr DS, et al. Decreased ex‐
pression of the human stem cell marker, Rex-1 (zfp-42), in renal cell carcinoma. Car‐
cinogenesis. 2006 Mar;27(3):499-507.
[110] Ben-Porath I, Thomson MW, Carey VJ, Ge R, Bell GW, Regev A, et al. An embryonic
stem cell-like gene expression signature in poorly differentiated aggressive human
tumors. Nat Genet. 2008 May;40(5):499-507.
[111] Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction
of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007
Nov 30;131(5):861-72.
[112] Yu J, Vodyanik M, Smuga-Otto K, Antosiewicz-Bourget J, Frane J, Tian S, et al. In‐
duced pluripotent stem cell lines derived from human somatic cells. Science.
2007;318(5858):1917.
[113] Wernig M, Meissner A, Foreman R, Brambrink T, Ku M, Hochedlinger K, et al. In vi‐
tro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature. 2007 Jul
19;448(7151):318-24.
[114] Wong DJ, Liu H, Ridky TW, Cassarino D, Segal E, Chang HY. Module map of stem
cell genes guides creation of epithelial cancer stem cells. Cell Stem Cell. 2008 Apr
10;2(4):333-44.
Pluripotent Stem Cells224
[115] Ohm J, Mali P, Van Neste L, Berman D, Liang L, Pandiyan K, et al. Cancer-Related
Epigenome Changes Associated with Reprogramming to Induced Pluripotent Stem
Cells. Cancer Research. 2010;70(19):7662.
[116] Mali P, Chou BK, Yen J, Ye Z, Zou J, Dowey S, et al. Butyrate greatly enhances deri‐
vation of human induced pluripotent stem cells by promoting epigenetic remodeling
and the expression of pluripotency-associated genes. Stem Cells. 2010 Apr;28(4):
713-20.
[117] Varambally S, Dhanasekaran SM, Zhou M, Barrette TR, Kumar-Sinha C, Sanda MG,
et al. The polycomb group protein EZH2 is involved in progression of prostate can‐
cer. Nature. 2002 Oct 10;419(6907):624-9.
[118] Kamminga LM, Bystrykh LV, de Boer A, Houwer S, Douma J, Weersing E, et al. The
Polycomb group gene Ezh2 prevents hematopoietic stem cell exhaustion. Blood. 2006
Mar 1;107(5):2170-9.
[119] Pasini D, Bracken AP, Jensen MR, Lazzerini Denchi E, Helin K. Suz12 is essential for
mouse development and for EZH2 histone methyltransferase activity. Embo J. 2004
Oct 13;23(20):4061-71.
[120] Bracken AP, Dietrich N, Pasini D, Hansen KH, Helin K. Genome-wide mapping of
Polycomb target genes unravels their roles in cell fate transitions. Genes Dev. 2006
May 1;20(9):1123-36.
[121] Bracken AP, Kleine-Kohlbrecher D, Dietrich N, Pasini D, Gargiulo G, Beekman C, et
al. The Polycomb group proteins bind throughout the INK4A-ARF locus and are dis‐
associated in senescent cells. Genes Dev. 2007 Mar 1;21(5):525-30.
[122] Dietrich N, Bracken AP, Trinh E, Schjerling CK, Koseki H, Rappsilber J, et al. Bypass
of senescence by the polycomb group protein CBX8 through direct binding to the
INK4A-ARF locus. Embo J. 2007 Mar 21;26(6):1637-48.
[123] Bracken AP, Pasini D, Capra M, Prosperini E, Colli E, Helin K. EZH2 is downstream
of the pRB-E2F pathway, essential for proliferation and amplified in cancer. Embo J.
2003 Oct 15;22(20):5323-35.
[124] Widschwendter M, Fiegl H, Egle D, Mueller-Holzner E, Spizzo G, Marth C, et al. Epi‐
genetic stem cell signature in cancer. Nat Genet. 2007 Feb;39(2):157-8.
[125] Liu S, Dontu G, Mantle ID, Patel S, Ahn NS, Jackson KW, et al. Hedgehog signaling
and Bmi-1 regulate self-renewal of normal and malignant human mammary stem
cells. Cancer Res. 2006 Jun 15;66(12):6063-71.
[126] Raman JD, Mongan NP, Tickoo SK, Boorjian SA, Scherr DS, Gudas LJ. Increased ex‐
pression of the polycomb group gene, EZH2, in transitional cell carcinoma of the
bladder. Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8570-6.
Epigenetic Reprogramming in Stem Cells
http://dx.doi.org/10.5772/56327
225
[127] Friedman JM, Liang G, Liu CC, Wolff EM, Tsai YC, Ye W, et al. The putative tumor
suppressor microRNA-101 modulates the cancer epigenome by repressing the poly‐
comb group protein EZH2. Cancer Res. 2009 Mar 15;69(6):2623-9.
Pluripotent Stem Cells226
